Results 71 to 80 of about 141,213 (164)

Managing remnant cholesterol: role of fenofibrate-statin therapy in reducing triglyceride-rich lipoproteins. [PDF]

Front Cardiovasc Med
Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Farnier M, Pushpa K, Tokgözoglu L, Zambon A, Berrou JP, Hermans MP.   +10 more
europepmc   +1 more source

The impact of statin therapy on the prognosis of hormone receptor-positive breast cancer: a systematic review and meta-analysis. [PDF]

Front Oncol
Ma X, Sun Y, Qi Y, Qu H, Zhang F.
europepmc   +1 more source

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity. [PDF]

Front Cardiovasc Med
Pala B, Piscione M, Di Marcantonio MC, Cribari F, Vitale R, Baldi T, Popolo A, Mincione G.   +7 more
europepmc   +1 more source

Isolated Gamma-Glutamyltransferase Elevation During Statin Therapy: A Diagnostic Pitfall and a Stepwise Management Framework to Prevent Unnecessary Discontinuation. [PDF]

Clin Case Rep
Yang J, He Y, Zhang Z.
europepmc   +1 more source

The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence. [PDF]

Pharmacol Res Perspect
Chiatto LM, Buccarello L, Carota G, Calabrò RS, Rifici C, Esposito E, Ardizzone A, Caruso G.   +7 more
europepmc   +1 more source

Adverse events associated with statin co-use in breast cancer patients: a disproportionality analysis based on the FDA Adverse Event Reporting System. [PDF]

Ther Adv Drug Saf
Zhang Y, Peng W, Yang W, Gao Y, Fan Y, Guo Q.   +5 more
europepmc   +1 more source

ROS-responsive nanocarriers for the delivery of atorvastatin in ischemic MCAO rats promoting neuroprotection. [PDF]

Mater Today Bio
Nagareddy R, Sundaram A, Kim JH, Kim JH, Vasvani S, Kweon S, Park IK, Jeong YY, Choi KH.   +8 more
europepmc   +1 more source

Thymoquinone protects against statin-induced cerebellar damage, apoptosis, and hepatic cytotoxicity in rats. [PDF]

Sci Rep
Ouies SM, Amin YA, Ragab NA, Ismae ZM, Hassany MA, Abd Elhameed BT, Hassan RGM, Mohammed WI, Abd-El Baki Ahmed M.   +8 more
europepmc   +1 more source

Non-adherence to Statin Treatment: A Narrative Review of Causes, Clinical Impact, and Preventive Strategies. [PDF]

Cureus
Mróz T, Morka J, Sobczak M, Morajko A.
europepmc   +1 more source

Cost-utility analysis of add-on ezetimibe to moderate-intensity statin versus moderate-intensity statin alone for secondary prevention in patients with acute coronary syndrome intolerant to high-intensity statin therapy in Thailand. [PDF]

Front Pharmacol
Promchit N, Chinwong S, Permsuwan U.
europepmc   +1 more source